Suppr超能文献

在囊性纤维化患者中使用外周置入中心静脉导管的并发症和实践差异:囊性纤维化患者外周置入静脉导管的前瞻性研究。

Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis: The Prospective Study of Peripherally Inserted Venous Catheters in People With Cystic Fibrosis Study.

机构信息

Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH; Division of Pediatric Pulmonology, Department of Pediatrics, Rainbow Babies and Children's Hospital, Cleveland, OH.

Maine Medical Center Research Institute, Scarborough, ME.

出版信息

Chest. 2023 Sep;164(3):614-624. doi: 10.1016/j.chest.2023.03.043. Epub 2023 Apr 3.

Abstract

BACKGROUND

Peripherally inserted central catheters (PICCs) are used commonly to administer antibiotics to people with cystic fibrosis (CF), but their use can be complicated by venous thrombosis and catheter occlusion.

RESEARCH QUESTION

Which participant-, catheter-, and catheter management-level attributes are associated with increased risk of complications of PICCs among people with CF?

STUDY DESIGN AND METHODS

This was a prospective observational study of adults and children with CF who received PICCs at 10 CF care centers in the United States. The primary end point was defined as occlusion of the catheter resulting in unplanned removal, symptomatic venous thrombosis in the extremity containing the catheter, or both. Three categories of composite secondary outcomes were identified: difficult line placement, local soft tissue or skin reactions, and catheter malfunction. Data specific to the participant, catheter placement, and catheter management were collected in a centralized database. Risk factors for primary and secondary outcomes were analyzed by multivariate logistic regression.

RESULTS

Between June 2018 and July 2021, 157 adults and 103 children older than 6 years with CF had 375 PICCs placed. Patients underwent 4,828 catheter-days of observation. Of the 375 PICCs, 334 (89%) were ≤ 4.5 F, 342 (91%) were single lumen, and 366 (98%) were placed using ultrasound guidance. The primary outcome occurred in 15 PICCs for an event rate of 3.11 per 1,000 catheter-days. No cases of catheter-related bloodstream infection occurred. Other secondary outcomes developed in 147 of 375 catheters (39%). Despite evidence of practice variation, no risk factors for the primary outcome and few risk factors for secondary outcomes were identified.

INTERPRETATION

This study affirmed the safety of contemporary approaches to inserting and using PICCs in people with CF. Given the low rate of complications in this study, observations may reflect a widespread shift to selecting smaller-diameter PICCs and using ultrasound to guide their placement.

摘要

背景

外周静脉置入中心导管(PICC)常用于向囊性纤维化(CF)患者输注抗生素,但它们的使用可能会因静脉血栓形成和导管堵塞而变得复杂。

研究问题

哪些患者、导管和导管管理水平的特征与 CF 患者 PICC 并发症的风险增加相关?

研究设计和方法

这是一项在美国 10 个 CF 护理中心进行的前瞻性观察性研究,纳入了接受 PICC 的成年和儿童 CF 患者。主要终点定义为导管堵塞导致计划外拔除、导管所在肢体有症状性静脉血栓形成或两者兼有。确定了三类复合次要结局:置管困难、局部软组织或皮肤反应以及导管功能障碍。在集中数据库中收集了与患者、导管放置和导管管理相关的特定数据。使用多变量逻辑回归分析了主要和次要结局的危险因素。

结果

在 2018 年 6 月至 2021 年 7 月期间,157 名成年人和 103 名 6 岁以上的儿童 CF 患者共置入 375 根 PICC。患者接受了 4828 天的导管观察。在 375 根 PICC 中,334 根(89%)为≤4.5F,342 根(91%)为单腔,366 根(98%)采用超声引导置入。15 根 PICC 发生主要结局,发生率为每 1000 天导管 3.11 例。无导管相关血流感染病例发生。375 根导管中,有 147 根(39%)发生了其他次要结局。尽管存在实践差异的证据,但未确定主要结局的危险因素,也未确定次要结局的几个危险因素。

解释

这项研究证实了在 CF 患者中插入和使用 PICC 的现代方法的安全性。考虑到本研究中并发症发生率较低,观察结果可能反映了一种广泛的转变,即选择更小直径的 PICC,并使用超声引导其放置。

相似文献

引用本文的文献

1
The Aging Patient with Cystic Fibrosis.患有囊性纤维化的老年患者
Drugs Aging. 2025 Apr 24. doi: 10.1007/s40266-025-01207-3.

本文引用的文献

4
CFTR modulators: transformative therapies for cystic fibrosis.CFTR 调节剂:囊性纤维化的变革性治疗方法。
J Manag Care Spec Pharm. 2021 Feb;27(2):281-284. doi: 10.18553/jmcp.2021.27.2.281.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验